Stockreport

Valeant Pharmaceuticals: Revisiting My $57 Price Target [Seeking Alpha]

VALEANT PHARMACEUTICALS  (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com
PDF Valeant Pharmaceuticals: Revisiting My $57 Price TargetSummaryI continue to believe assets sales are the key for Valeant shares to see higher levels.Based on my latest f [Read more]